A detailed history of Capital Management Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Capital Management Corp holds 340,960 shares of HRMY stock, worth $11.8 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
340,960
Previous 237,652 43.47%
Holding current value
$11.8 Million
Previous $9.49 Million 23.57%
% of portfolio
2.44%
Previous 1.94%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$31.86 - $41.49 $3.29 Million - $4.29 Million
103,308 Added 43.47%
340,960 $11.7 Million
Q3 2024

Oct 30, 2024

SELL
$30.0 - $39.95 $71,640 - $95,400
-2,388 Reduced 0.99%
237,652 $9.49 Million
Q2 2024

Jul 25, 2024

BUY
$28.81 - $33.01 $894,435 - $1.02 Million
31,046 Added 14.85%
240,040 $7.24 Million
Q1 2024

May 10, 2024

BUY
$29.93 - $35.06 $6.26 Million - $7.33 Million
208,994 New
208,994 $7.02 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.04B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Capital Management Corp Portfolio

Follow Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Corp with notifications on news.